EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 1980. Start Trial.
Date Value
December 31, 2025 -3.002
December 31, 2024 -0.5315
December 31, 2023 0.0453
December 31, 2022 1.707
December 31, 2021 -1.050
December 31, 2020 -1.114
December 31, 2019 0.0325
December 31, 2018 0.6825
December 31, 2017 1.30
December 31, 2016 0.92
December 31, 2015 1.70
December 31, 2014 2.34
December 31, 2013 1.58
December 31, 2012 1.52
December 31, 2011 1.22
December 31, 2010 0.68
December 31, 2009 0.30
December 31, 2008 -1.10
December 31, 2007 -5.984
March 31, 2006 0.79
March 31, 2005 0.74
March 31, 2004 1.21
March 31, 2003 0.9667
Date Value
March 31, 2002 0.9067
March 31, 2001 0.1289
March 31, 2000 0.5244
March 31, 1999 0.4044
March 31, 1998 0.3644
March 31, 1997 0.2311
March 31, 1996 0.3822
March 31, 1995 0.4504
March 31, 1994 0.2756
March 31, 1993 0.2726
March 31, 1992 0.00
March 31, 1991 0.00
March 31, 1990 0.00
March 31, 1989 0.00
March 31, 1988 0.00
March 31, 1987 0.00
March 31, 1986 0.00
March 31, 1985 0.00
March 31, 1984 0.00
March 31, 1983 0.00
March 31, 1982 0.00
March 31, 1981 0.00
March 31, 1980 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Pfizer Inc. 1.356
Eli Lilly & Co. 22.95
Merck & Co., Inc. 7.281
Bristol Myers Squibb Co. 3.460
Johnson & Johnson 11.03